STK40 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.565000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.330000E-02
Normal-vs-Stage2
4.388800E-01
Normal-vs-Stage3
2.174100E-02
Normal-vs-Stage4
7.508800E-01
Stage1-vs-Stage2
8.098500E-02
Stage1-vs-Stage3
1.063360E-01
Stage1-vs-Stage4
1.234820E-01
Stage2-vs-Stage3
1.467800E-01
Stage2-vs-Stage4
5.844600E-01
Stage3-vs-Stage4
5.569600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.099600E-01
Normal-vs-AfricanAmerican
7.637800E-01
Normal-vs-Asian
9.892600E-01
Caucasian-vs-AfricanAmerican
4.198200E-01
Caucasian-vs-Asian
6.894300E-02
AfricanAmerican-vs-Asian
7.127600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.357200E-01
Normal-vs-Female
2.555000E-01
Male-vs-Female
7.621200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.990200E-01
Normal-vs-Age(41-60Yrs)
7.686400E-01
Normal-vs-Age(61-80Yrs)
2.536000E-01
Normal-vs-Age(81-100Yrs)
2.569600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.780000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.109800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.305600E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.637430E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.876510E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.034000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.961400E-01
Normal-vs-Daily Drinker
2.715400E-01
Normal-vs-Weekly Drinker
1.335000E-01
Normal-vs-Occasional Drinker
6.153000E-01
Normal-vs-Social Drinker
1.266770E-01
Non Drinker-vs-Daily Drinker
9.226200E-01
Non Drinker-vs-Weekly Drinker
7.623600E-01
Non Drinker-vs-Occasional Drinker
3.408600E-01
Non Drinker-vs-Social Drinker
7.233600E-01
Daily Drinker-vs-Weekly Drinker
6.272600E-01
Daily Drinker-vs-Occasional Drinker
3.133200E-01
Daily Drinker-vs-Social Drinker
6.253200E-01
Weekly Drinker-vs-Occasional Drinker
1.714820E-01
Weekly Drinker-vs-Social Drinker
9.906200E-01
Occasional Drinker-vs-Social Drinker
1.622420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.091400E-01
Normal-vs-Grade 2
1.661580E-01
Normal-vs-Grade 3
3.155400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.342000E-01
Grade 1-vs-Grade 3
3.890800E-01
Grade 1-vs-Grade 4
4.091400E-01
Grade 2-vs-Grade 3
1.921790E-01
Grade 2-vs-Grade 4
1.661580E-01
Grade 3-vs-Grade 4
3.155400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.906400E-01
Normal-vs-NonDiabetic
2.211200E-01
Diabetic-vs-NonDiabetic
9.307600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.083600E-01
Normal-vs-NoPancreatitis
2.315000E-01
Pancreatitis-vs-NoPancreatitis
3.528600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.473760E-01
Normal-vs-N1
3.948000E-01
N0-vs-N1
3.623600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.454400E-01
Normal-vs-TP53-NonMutant
4.047400E-01
TP53-Mutant-vs-TP53-NonMutant
3.746400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
